Articles

Videos

Podcasts

Clinical

Khalili and his colleagues have completed preclinical studies that have shown that EBT-101 can effectively excise HIV proviral DNA from the genomes of different cells and tissues, including HIV-infected human cells and cells and tissues of humanized mice.

New Research Provides Information for First Trial of CRISPR-Based HIV Therapy in Humans

The 5 largest specialty therapeutic groups—oncology, autoimmune, immunology, HIV, and multiple sclerosis—will account for 74% of specialty spending growth over the next five years.

Establishing Specialty Pharmacy Beyond US Borders: Opportunities and Challenges

The findings, published in the Journal of the American Heart Association, add to a list of cardiac risks experienced by patients with HIV.

Patients With HIV Have an Increased Risk of Sudden Cardiac Death

Harry Webster, RPh, a registered pharmacist at Walgreens and a member of the LGBTQIA+ community, discusses the impact of stigma associated with PrEP and HIV on patients seeking to treat or prevent HIV.

How Stigma, Unconscious Bias Impacts Health Outcomes for Patients Seeking, Using PrEP for HIV Prevention

Collaborative efforts between patients, physicians, pharmacists, and other essential personnel can further promote the effectiveness of PrEP regimens. 

Best PrEP Practices for People at High Risk for HIV

Brad McElya, PharmD, director of specialty health solutions at Walgreens, discusses the critical role pharmacists play in providing HIV prevention drugs in communities across America.

Expert: Two PrEP Drugs Now Covered by Nearly All Health Insurers, Heightening Role of Pharmacists in Fight Against HIV 

Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV. 

Health System-Based Specialty Pharmacy Offers Unique Advantages in HIV Care

Analyzing how off-target antibodies may be undermining HIV vaccine prototypes allows for design improvements. 

Study: HIV Vaccines in Early Human Trials Undermined by Off-Target Antibodies

Multimorbidity, health-related quality of life, and stigma and discrimination continue to be major issues for people living with HIV, including those who have achieved viral suppression, according to a consensus statement from a multidisciplinary panel of HIV experts published in Nature Communications.

Global Panel Finds Multimorbidity, Quality of Life, Discrimination Still Major Issues for Patients Living With HIV

Truvada is a medicine people at risk for HIV should take to prevent infection with the virus from various ways, such as sex or injection drug use.